The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature Reviews Immunology · doi:10.1038/nri746 · Cited by 2,291
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Tacken, P. J., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2173 · Cited by 750
Toll-Like Receptors: Linking Innate and Adaptive Immunity
Pasare, C., & Medzhitov, R. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-387-24180-9_2 · Cited by 660
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.693 · Cited by 610
Self-citationProfessional and non-professional phagocytes: an introduction
Rabinovitch, M. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)88955-2 · Cited by 547
TLR-signaling Networks: An Integration of Adaptor Molecules, Kinases, and Cross-talk
Brown, J., Wang, H., Hajishengallis, G. N., & Martin, M. (2011) · Journal of Dental Research · doi:10.1177/0022034510381264 · Cited by 534
Cancer Immunotherapy by Dendritic Cells
Melief, C. J. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.004 · Cited by 508
The CD8+ dendritic cell subset
Shortman, K., & Heath, W. R. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00870.x · Cited by 487
Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L., Saltzman, W. M., & Hanlon, D. J. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02268.x · Cited by 420
The dominant role of CD8+dendritic cells in cross-presentation is not dictated by antigen capture
Schnorrer, P., Behrens, G. M. N., Wilson, N. S., Pooley, J. L., Smith, C. M., El-Sukkari, D., Davey, G., Kupresanin, F., Li, M., Maraskovsky, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601956103 · Cited by 383
Specialized role of migratory dendritic cells in peripheral tolerance induction
Idoyaga, J., Fiorese, C., Zbytnuik, L., Lubkin, A., Miller, J., Malissen, B., Mucida, D., Merad, M., & Steinman, R. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65260 · Cited by 305
Cruz, L. J., Tacken, P. J., Fokkink, R., Joosten, B., Stuart, M. C., Albericio, F., Torensma, R., & Figdor, C. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.013 · Cited by 281 · cited 2×
“Alternatively, active vaccine-targeting strategies via CD40, as shown in this study, or through C-type lectins such as DEC-205, DC-SIGN and Glec9a greatly improves Ag delivery, processing and T cell priming by DC over non-targeted controls [14,16,23,28,29].”
BackgroundMethodSelf-citationSchreibelt, G., Klinkenberg, L. J. J., Cruz, L. J., Tacken, P. J., Tel, J., Kreutz, M., Adema, G. J., Brown, G. D., Figdor, C. G., & de Vries, I. J. M. (2012) · Blood · doi:10.1182/blood-2011-08-373944 · Cited by 252
Self-citationCruz, L. J., Rosalia, R. A., Kleinovink, J. W., Rueda, F., Löwik, C. W. G. M., & Ossendorp, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.040 · Cited by 235
Self-citationImmune system targeting by biodegradable nanoparticles for cancer vaccines
Silva, J. M., Videira, M., Gaspar, R., Préat, V., & Florindo, H. F. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.010 · Cited by 233
Kamphorst, A. O., Guermonprez, P., Dudziak, D., & Nussenzweig, M. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001205 · Cited by 208
Cohn, L., Chatterjee, B., Esselborn, F., Smed-Sörensen, A., Nakamura, N., Chalouni, C., Lee, B.-C., Vandlen, R., Keler, T., Lauer, P., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121251 · Cited by 200
Schuurhuis, D. H., Laban, S., Toes, R. E. M., Ricciardi-Castagnoli, P., Kleijmeer, M. J., van der Voort, E. I. H., Rea, D., Offringa, R., Geuze, H. J., Melief, C. J. M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.145 · Cited by 192
Self-citationZhu, Q., Egelston, C., Gagnon, S., Sui, Y., Belyakov, I. M., Klinman, D. M., & Berzofsky, J. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39293 · Cited by 186
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Tacken, P. J., Zeelenberg, I. S., Cruz, L. J., van Hout-Kuijer, M. A., van de Glind, G., Fokkink, R. G., Lambeck, A. J. A., & Figdor, C. G. (2011) · Blood · doi:10.1182/blood-2011-07-367615 · Cited by 173
Self-citationLim, T. S., Goh, J. K. H., Mortellaro, A., Lim, C. T., Hämmerling, G. J., & Ricciardi-Castagnoli, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045185 · Cited by 168
Palucka, K., Ueno, H., Fay, J., & Banchereau, J. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02317.x · Cited by 162
Fransen, M. F., Sluijter, M., Morreau, H. M., Arens, R., & Melief, C. J. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2888 · Cited by 153
Kroczek, R. A., & Henn, V. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00014 · Cited by 133
Targeting dendritic cells—why bother?
Kreutz, M., Tacken, P. J., & Figdor, C. G. (2013) · Blood · doi:10.1182/blood-2012-09-452078 · Cited by 125
Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine
Schuurhuis, D. H., van Montfoort, N., Ioan‐Facsinay, A., Jiawan-Lalai, R., Camps, M. G. M., Nouta, J., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4573 · Cited by 119
Self-citationGu, L., Ruff, L. E., Qin, Z., Corr, M., Hedrick, S. Μ., & Sailor, M. J. (2012) · Advanced Materials · doi:10.1002/adma.201200776 · Cited by 117
Silva, A. L., Rosalia, R. A., Sazak, A., Carstens, M. G., OSSENDORP, F. A., Oostendorp, J., & Jiskoot, W. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.006 · Cited by 117
Self-citationActivation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles
Hamdy, S. I., Haddadi, A., Shayeganpour, A., Samuel, J., & Lavasanifar, A. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0459-9 · Cited by 113
Fernandez, É. M., Cruz, L. J., Ghinnagow, R., Fontaine, J., Bialecki, E., Frisch, B., Trottein, F., & Faveeuw, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303029 · Cited by 90
Self-citationSchliehe, C., Redaelli, C., Engelhardt, S., Fehlings, M. G., Mueller, M., van Rooijen, N., Thiry, M., Hildner, K., Weller‡, H., & Groettrup, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002084 · Cited by 79
Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors
Schjetne, K. W., Fredriksen, A. B., & Bogen, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4169 · Cited by 70
Development of antigen cross-presentation capacity in dendritic cells
Dresch, C., Leverrier, Y., Marvel, J., & Shortman, K. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.009 · Cited by 67
Kempf, M., Mandal, B., Jilek, S., Thiele, L., Vörös, J., Textor, M., Merkle, H. P., & Walter, E. (2003) · Journal of drug targeting · doi:10.1080/1061186031000072978 · Cited by 60
Raghuwanshi, D., Mishra, V., Suresh, M. R., & Kaur, K. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.036 · Cited by 55
Ruiling, H., Zhu, J., Yang, X., & Xu, H. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32860 · Cited by 55
Welters, M. J. P., Bijker, M. S., van den Eeden, S. J. F., Franken, K. L. M. C., Melief, C. J. M., Offringa, R., & van der Burg, S. H. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.049 · Cited by 51
Slütter, B., Pewe, L. L., Lauer, P., & Harty, J. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202790 · Cited by 43
van Montfoort, N., Mangsbo, S. M., Camps, M. G. M., van Maren, W. W. C., Verhaart, I. E. C., Waisman, A., Drijfhout, J. W., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2012) · European Journal of Immunology · doi:10.1002/eji.201141613 · Cited by 42
Self-citationMackey, M. F., Wang, Z., Eichelberg, K., & Germain, R. N. (2003) · European Journal of Immunology · doi:10.1002/eji.200323729 · Cited by 39
Gottschalk, C., Damuzzo, V., Gotot, J., Kroczek, R., Yagita, H., Murphy, K., Knolle, P., Ludwig-Portugall, I., & Kurts, C. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101022 · Cited by 39
Mueller, M., Schlosser, E., Gander, B. A., & Groettrup, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25914 · Cited by 35
Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine
Hangalapura, B. N., Oosterhoff, D., de Groot, J., Boon, L., Tüting, T., van den Eertwegh, A. J. M., Gerritsen, W. R., van Beusechem, V. W., Pereboev, A. V., Curiel, D. T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0804 · Cited by 35
Gao, X., Wang, S., Fan, Y., Bai, H., Yang, J., & Yang, X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009281 · Cited by 18
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Yang, M., Li, J., Gu, P., & Fan, X. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.010 · Cited by 670
Metadata
- Authors
- Rosalia, R. A., Cruz, L. J., van Duikeren, S., Tromp, A. T., Silva, A. L., Jiskoot, W., de Gruijl, T., Löwik, C., Oostendorp, J., van der Burg, S. H., & Ossendorp, F.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 40
- Pages
- 88-97
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W1973193910
- Cited by
- 269
- References
- 53
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.